| Literature DB >> 35832498 |
Yong-Gang He1, Xiao-Min Yang1, Xue-Hui Peng1, Jing Li1, Wen Huang1, Gui-Cang Jian1, Jing Wu1, Yi-Chen Tang1, Liang Wang1, Xiao-Bing Huang1.
Abstract
Objective: To explore the association between a modified Blumgart anastomosis technique and the operative time and surgical complications.Entities:
Keywords: POPF; blumgart anastomosis; laparoscopic pancreatoduodenectomy; operation time; pancreaticojejunostomy
Year: 2022 PMID: 35832498 PMCID: PMC9271827 DOI: 10.3389/fsurg.2022.931109
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Schematic diagram of the modified Blumgart anastomosis. Step 1 (A–D): suturing of the posterior wall of the pancreas and jejunum. In steps (A,B) the superior border of the pancreas was penetrated. Then, the seromuscular layer of the jejunum was sutured and knotted. Step c shows the suturing and fixing of the superior border of the pancreas from the top to bottom through the entire pancreas and the suturing of the jejunum. Step 2 (E–H): the 8-shaped pancreaticojejunostomy anastomosis suture. Step (D) shows a small opening on the jejunum side made for the anastomosis. Step (E) shows the first 8-shaped stitch on the posterior wall of the pancreaticojejunostomy. Steps (F,G) show the 8-shaped sutures of the second and third stitches. Step (I) shows that the inferior border of the pancreas was penetrated through the complete layer. Then, the seromuscular layer of the jejunum was sutured and knotted with the unknotted suture in Step 1. Step 3 (K,L): the anterior wall of the pancreas was sutured with the seromuscular layer of the jejunum.
Patient characteristics and intraoperative factors.
| Characteristics | Traditional group ( | Modified group ( |
|
|---|---|---|---|
| Gender (male/female) | 105/72 | 62/43 | 0.964 |
| Age (years) | 58.85 ± 10.07 | 58.55 ± 11.7 | 0.823 |
| BMI (kg/m2)* | 23.23 ± 1.96 | 22.89 ± 3.89 | 0.411 |
| Pancreatic duct diameter (mm) | 3.43 ± 1.08 | 3.44 ± 2.01 | <0.001 |
| Operation time unit (min) | 353.56 ± 50.27 | 323.8 ± 53.57 | <0.001 |
| Pancreaticojejunostomy time unit (min) | 32.37 ± 3.47 | 21.41 ± 3.03 | <0.001 |
| Intraoperative blood loss (mL) | 182.37 ± 78.31 | 185.43 ± 73.09 | 0.746 |
| conversion to open surgery | 12 (6.8%) | 2(1.9%) | 0.068 |
| American Society of Anesthesiology classification | 0.467 | ||
| I | 61 (34.5%) | 43 (41%) | |
| II | 101 (57%) | 52 (49.5%) | |
| III | 15 (8.5%) | 10 (9.5%) | |
| Disease | 0.324 | ||
| Pancreatic cancer | 43 (24.3%) | 30 (28.6%) | |
| Cholangiocarcinoma | 25 (14.1%) | 14 (13.3%) | |
| Duodenal carcinoma | 20 (11.3%) | 14 (13.3%) | |
| Periampullary carcinoma | 17 (9.6%) | 18 (17.2%) | |
| Pancreatic neuroendocrine tumor | 17 (9.6%) | 6 (5.7%) | |
| Intraductal papillary mucinous neoplasm | 20 (11.3%) | 8 (7.6%) | |
| Duodenal stromal tumor | 15 (8.5%) | 4 (3.8%) | |
| Papillary adenoma of the duodenum | 9 (5.1%) | 4 (3.8%) | |
| Cystadenoma of the pancreas | 9 (5.1%) | 4 (3.8%) | |
| Pancreatic duct stones with chronic pancreatitis | 2 (1.1%) | 3 (2.9%) |
P < 0.05 is considered statistically significant. Data are expressed as mean ± SD.
Incidence of postoperative complications.
| Postoperative complications | Traditional group ( | Modified group ( | t/X2 |
|
|---|---|---|---|---|
| Clavien–Dindo Classification | 13.092 | 0.004 | ||
| Grade I | 41 (23.2%) | 12 (11.4%) | ||
| Grade II | 34 (19.2%) | 11 (10.5%) | ||
| Grade III | 10 (5.6%) | 5 (4.8%) | ||
| Grade IV–V | 0 (0%) | 0 (0%) | ||
| Surgical re-intervention | 6 (3.4%) | 2 (1.9%) | 0.527 | 0.468 |
| Bleeding | 21 (11.9%) | 5 (4.8%) | 3.972 | 0.046 |
| Gastrointestinal bleeding | 14 (7.9%) | 4 (3.8%) | ||
| Intraperitoneal hemorrhage | 7 (4%) | 1 (0.95%) | ||
| Postoperative pancreatic fistula | 45 (25.4%) | 11 (10.5%) | 22.183 | <0.001 |
| Biochemical fistula | 31 (17.5%) | 7 (6.7%) | ||
| Grade B | 10 (5.6%) | 4 (3.8%) | ||
| Grade C | 4 (2.3%) | 0 (0%) | ||
| Bile leakage | 6 (3.4%) | 2 (1.9%) | 0.527 | 0.468 |
| Chylous leakage | 2 (1.1%) | 1 (0.95%) | 0.020 | 0.888 |
| Pulmonary infection | 6 (3.4%) | 2 (1.9%) | 0.527 | 0.468 |
| Abdominal infection | 5 (2.8%) | 2 (1.9%) | 0.230 | 0.631 |
| Delayed gastric emptying | 12 (6.8%) | 4 (3.8%) | 1.086 | 0.297 |
| Ascites | 2 (1.1%) | 1 (0.95%) | 0.020 | 0.888 |
P < 0.05 is considered statistically significant.
Independent factors affecting operation time.
| Variables | β | SE | Standardization β | 95% CI | |
|---|---|---|---|---|---|
| Type of surgery | |||||
| Traditional | Reference | ||||
| Modified | −48.507 | 12.476 | −0.438 | −73.074 to −23.941 | <0.001 |
| BMI | 0.069 | 1.106 | 0.004 | −2.109 to −2.247 | 0.951 |
| Age | 0.314 | 0.292 | 0.063 | −0.26 to −0.889 | 0.283 |
| Intraoperative blood loss | 0.025 | 0.041 | 0.036 | −0.056 to −0.106 | 0.541 |
| Pancreaticojejunostomy time | −1.784 | 0.958 | −0.208 | −3.67 to −0.103 | 0.064 |
| Pancreatic duct diameter | 0.158 | 2.151 | 0.005 | −4.076 to −4.393 | 0.941 |
| Disease | |||||
| Periampullary carcinoma | Reference | ||||
| Pancreatic cancer | −27.344 | 14.786 | −0.225 | −56.325 to −1.637 | 0.062 |
| Intraductal papillary mucinous neoplasm | −22.554 | 13.476 | −0.127 | −49.088 to −3.981 | 0.095 |
| Duodenal stromal tumor | −19.036 | 14.866 | −0.090 | −48.308 to −10.235 | 0.201 |
| Cystadenoma of the pancreas | −13.544 | 16.846 | −0.053 | −46.715 to −19.627 | 0.422 |
| Papillary adenoma of the duodenum | −11.304 | 16.969 | −0.045 | −44.717 to –22.109 | 0.506 |
| Cholangiocarcinoma | −18.425 | 12.175 | −0.119 | −42.399 to −5.548 | 0.131 |
| Pancreatic neuroendocrine tumor | 1.605 | 14.385 | 0.008 | −26.72 to −29.93 | 0.911 |
| Duodenal carcinoma | −31.222 | 15.939 | −0.191 | −62.462 to −0.018 | 0.093 |
| Pancreatic duct stones with chronic pancreatitis | −38.155 | 24.983 | −0.095 | −87.349 to −11.038 | 0.128 |
| American Society of Anesthesiology classification | |||||
| I | Reference | ||||
| II | −0.173 | 6.703 | −0.002 | −13.371 to −13.024 | 0.979 |
| III | −1.586 | 11.951 | −0.008 | −25.118 to −21.947 | 0.895 |
P < 0.05 is considered statistically significant.